Hmm. His prolonged silence has forced the share price down so much so it has limited his equity raising options to advance Vapendavir in a timely (before shareholders start dying of old age) manner.
Its good to see they update their website in a timely manner.
Not so clinicaltrials.gov.
marketing effort by r.h.p, page-3
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)